Suzhou Basecare Medical Corporation Limited (Basecare Medical) has scheduled a board meeting for 28 August 2026. According to the company’s announcement dated 18 August 2026, directors will consider and approve the consolidated interim results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.
The meeting will also address other routine board matters. Basecare Medical’s board currently comprises eight directors, including three executive directors, two non-executive directors and three independent non-executive directors.
The announcement was signed by Chairman and General Manager Dr. Liang Bo in Suzhou, PRC.